Fermented cereal with specific bifidobacteria normalizes bowel movements in elderly nursing home residents. A randomized, controlled trial.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 17653486)

Published in J Nutr Health Aging on July 26, 2007

Authors

K H Pitkala1, T E Strandberg, U H Finne Soveri, A C Ouwehand, T Poussa, S Salminen

Author Affiliations

1: K.H. Pitkala, Helsinki University Hospital, Department of Medicine, Clinics of General Internal Medicine and Geriatrics, Po Box 340, Fin-00029 HUS, Finland. kaisu.pitkala@kolumbus.fi

Articles citing this

Aging of the human metaorganism: the microbial counterpart. Age (Dordr) (2011) 1.36

Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide. Aliment Pharmacol Ther (2013) 1.21

Probiotics modulate the Bifidobacterium microbiota of elderly nursing home residents. Age (Dordr) (2008) 0.99

A systematic mapping review of randomized controlled trials (RCTs) in care homes. BMC Geriatr (2012) 0.90

Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol (2016) 0.85

Inclusion of fermented foods in food guides around the world. Nutrients (2015) 0.82

Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases. Front Microbiol (2015) 0.82

Can prebiotics and probiotics improve therapeutic outcomes for undernourished individuals? Gut Microbes (2013) 0.82

The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12(®). Microorganisms (2014) 0.81

Prevalence of constipation symptoms in fecally incontinent nursing home residents. J Am Geriatr Soc (2009) 0.79

Geriatric Respondents and Non-Respondents to Probiotic Intervention Can be Differentiated by Inherent Gut Microbiome Composition. Front Microbiol (2015) 0.79

Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br J Nutr (2015) 0.77

Articles by these authors

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet (2001) 6.82

Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ (1996) 3.79

Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol (2001) 3.61

Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ (2001) 2.91

Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci (1992) 2.78

Effect of statins on C-reactive protein in patients with coronary artery disease. Lancet (1999) 2.63

Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ (2000) 2.54

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics (1999) 2.45

Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol (1999) 2.35

Probiotics: effects on immunity. Am J Clin Nutr (2001) 2.10

Probiotics in the management of atopic eczema. Clin Exp Allergy (2000) 2.00

Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res (2002) 1.92

Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med (1990) 1.90

Confusion assessment method in the diagnostics of delirium among aged hospital patients: would it serve better in screening than as a diagnostic instrument? Int J Geriatr Psychiatry (2002) 1.84

Blood pressure and mortality in an older population. A 5-year follow-up of the Helsinki Ageing Study. Eur Heart J (1997) 1.75

Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy (2005) 1.75

Predictors and subjective causes of loneliness in an aged population. Arch Gerontol Geriatr (2005) 1.67

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther (2005) 1.64

The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol Lett (1998) 1.62

Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Arch Oral Biol (2002) 1.62

Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med (1990) 1.54

Ability of dairy strains of lactic acid bacteria to bind a common food carcinogen, aflatoxin B1. Food Chem Toxicol (1998) 1.52

Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy (2007) 1.49

Polyunsaturated fatty acids in maternal diet, breast milk, and serum lipid fatty acids of infants in relation to atopy. Allergy (2001) 1.47

Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. Int J Food Microbiol (1995) 1.46

Probiotics: a role in the treatment of intestinal infection and inflammation? Gut (2002) 1.46

Probiotics demonstrating efficacy in clinical settings. Clin Infect Dis (2001) 1.46

Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis (2006) 1.44

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol (2000) 1.43

Surface binding of aflatoxin B(1) by lactic acid bacteria. Appl Environ Microbiol (2001) 1.37

Quality assurance criteria for probiotic bacteria. Am J Clin Nutr (2001) 1.37

Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy. Br J Cancer (2011) 1.36

Positive life orientation as a predictor of 10-year outcome in an aged population. J Clin Epidemiol (2004) 1.31

Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol (2001) 1.30

Probiotics reduce the prevalence of oral candida in the elderly--a randomized controlled trial. J Dent Res (2007) 1.30

The effect of enhanced hygiene practices on absences due to infectious diseases among children in day care centers in Helsinki. Infection (2004) 1.28

Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci (1994) 1.27

Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin Diagn Lab Immunol (2001) 1.24

Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria. Appl Environ Microbiol (2000) 1.21

Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett Appl Microbiol (2007) 1.20

Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol (2008) 1.19

Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol (2001) 1.19

Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin Exp Allergy (1998) 1.18

Chemical, physical and enzymatic pre-treatments of probiotic lactobacilli alter their adhesion to human intestinal mucus glycoproteins. Int J Food Microbiol (2000) 1.17

Nutrition economics - characterising the economic and health impact of nutrition. Br J Nutr (2010) 1.14

Ability of Lactobacillus and Propionibacterium strains to remove aflatoxin B, from the chicken duodenum. J Food Prot (2000) 1.14

Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol. Arterioscler Thromb Vasc Biol (2000) 1.13

Glucose tolerance and blood pressure: long term follow up in middle aged men. BMJ (1991) 1.13

The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunol Med Microbiol (1999) 1.11

Physicochemical alterations enhance the ability of dairy strains of lactic acid bacteria to remove aflatoxin from contaminated media. J Food Prot (1998) 1.11

Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr (1994) 1.10

Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy (2008) 1.10

Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study. Scand J Rheumatol (2003) 1.09

Lactobacilli and bacteremia in southern Finland, 1989-1992. Clin Infect Dis (1996) 1.07

Ability of dairy strains of lactic acid bacteria to bind aflatoxin M1 in a food model. J Food Prot (2000) 1.07

The allergy epidemic extends beyond the past few decades. Clin Exp Allergy (2004) 1.06

Aflatoxin B1 binding by dairy strains of lactic acid bacteria and bifidobacteria. J Dairy Sci (2001) 1.04

Determinants of respiratory system input impedance and bronchodilator response in healthy Finnish preschool children. Clin Physiol Funct Imaging (2002) 1.04

Permanent colonization by Lactobacillus casei is hindered by the low rate of cell division in mouse gut. Appl Environ Microbiol (2004) 1.03

Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol (1988) 1.03

Good adhesion properties of probiotics: a potential risk for bacteremia? FEMS Immunol Med Microbiol (2001) 1.03

Human ileostomy glycoproteins as a model for small intestinal mucus to investigate adhesion of probiotics. Lett Appl Microbiol (1999) 1.03

Oral adhesion and survival of probiotic and other lactobacilli and bifidobacteria in vitro. Oral Microbiol Immunol (2006) 1.03

Gut bacteria and health foods--the European perspective. Int J Food Microbiol (2002) 1.02

Removal of common Fusarium toxins in vitro by strains of Lactobacillus and Propionibacterium. Food Addit Contam (2002) 1.02

Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards. Int Psychogeriatr (2004) 1.01

Unmet needs in information flow between breast cancer patients, their spouses, and physicians. Support Care Cancer (2004) 1.00

Xylo-oligosaccharides enhance the growth of bifidobacteria and Bifidobacterium lactis in a simulated colon model. Benef Microbes (2010) 0.99

Lactobacillus crispatus and its nonaggregating mutant in human colonization trials. J Dairy Sci (2001) 0.98

Lipid composition of bile and gallbladder mucosa in patients with acalculous cholesterolosis. Gastroenterology (1982) 0.97

Assessment of adhesion properties of novel probiotic strains to human intestinal mucus. Int J Food Microbiol (2001) 0.97

Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc (1998) 0.97

Effects of polyunsaturated fatty acids in growth medium on lipid composition and on physicochemical surface properties of lactobacilli. Appl Environ Microbiol (2004) 0.96

Adhesion of inactivated probiotic strains to intestinal mucus. Lett Appl Microbiol (2000) 0.96

Microbial interactions to intestinal mucosal models. Methods Enzymol (2001) 0.96

Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors. Curr Microbiol (2001) 0.96

Is it possible to reduce polypharmacy in the elderly? A randomised, controlled trial. Drugs Aging (2001) 0.95

Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis. Clin Exp Allergy (2010) 0.95

Safety of probiotic bacteria. Asia Pac J Clin Nutr (1996) 0.95

Panose, a new prebiotic candidate. Lett Appl Microbiol (2009) 0.93

Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease. Curr Pharm Des (2008) 0.92

Combining strains of lactic acid bacteria may reduce their toxin and heavy metal removal efficiency from aqueous solution. Lett Appl Microbiol (2007) 0.92

Gut microflora interactions with xylitol in the mouse, rat and man. Food Chem Toxicol (1985) 0.92

Secular trends in self-reported functioning, need for assistance and attitudes towards life: 10-year differences of three older cohorts. J Am Geriatr Soc (2001) 0.92

Does breast cancer change patients' dietary habits? Eur J Clin Nutr (2000) 0.92

Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria. Allergy (2015) 0.92

Impact of maternal diet during pregnancy and breastfeeding on infant metabolic programming: a prospective randomized controlled study. Eur J Clin Nutr (2010) 0.92

Ingestion of heat-treated Lactobacillus rhamnosus GG prevents development of atopic dermatitis in NC/Nga mice. Clin Exp Allergy (2007) 0.91

Interventions for preventing injuries in the agricultural industry. Cochrane Database Syst Rev (2008) 0.91

In vitro synthesis of triglycerides and cholesterol in human gallbladder mucosa. Scand J Gastroenterol (1982) 0.91

Workshop Report: concepts and methods in the economics of nutrition--gateways to better economic evaluation of nutrition interventions. Br J Nutr (2012) 0.91

Rapid removal of lead and cadmium from water by specific lactic acid bacteria. Int J Food Microbiol (2006) 0.90

Characterisation of aflatoxin and deoxynivalenol exposure among pregnant Egyptian women. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2012) 0.90

Degradation of 16S rRNA and attributes of viability of viable but nonculturable probiotic bacteria. Lett Appl Microbiol (2008) 0.90

Sustained reduction in bronchial hyperresponsiveness with inhaled fluticasone propionate within three days in mild asthma: time course after onset and cessation of treatment. Thorax (2003) 0.89

Colonization and fecal enzyme activities after oral Lactobacillus GG administration in elderly nursing home residents. Ann Nutr Metab (1992) 0.89